KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $792,000 | +19.5% | 4,400 | -31.2% | 0.01% | +20.0% |
| Q2 2017 | $663,000 | -29.0% | 6,400 | -46.2% | 0.01% | -28.6% |
| Q1 2017 | $934,000 | -1.9% | 11,900 | -23.0% | 0.01% | +100.0% |
| Q4 2015 | $952,000 | +271.9% | 15,450 | +235.9% | 0.01% | +75.0% |
| Q3 2015 | $256,000 | -89.7% | 4,600 | -88.8% | 0.00% | -87.5% |
| Q2 2015 | $2,492,000 | -60.6% | 40,900 | -62.7% | 0.03% | -63.2% |
| Q1 2015 | $6,322,000 | +358.4% | 109,600 | +358.6% | 0.09% | +383.3% |
| Q4 2014 | $1,379,000 | – | 23,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |